@article{oai:repo.qst.go.jp:00079823,
 author = {Sudo, Hitomi and B Tsuji, Atsushi and Sugyo, Aya and Kurosawa, Gene and Kurosawa, Yoshikazu and Alexander, David and Tsuda, Hiroyuki and Saga, Tsuneo and Higashi, Tatsuya and Hitomi, Sudo and Atsushi, Tsuji and Aya, Sugyo and Tsuneo, Saga and Tatsuya, Higashi},
 issue = {7},
 journal = {International journal of molecular sciences},
 month = {Mar},
 note = {CD73 is an ectonucleotidase regulating extracellular adenosine concentration and plays an important role in adenosine-mediated immunosuppressive pathways. The efficacy of CD73-targeted therapy depends on the expression levels of CD73; therefore, monitoring CD73 status in cancer patients would provide helpful information for selection of patients who would benefit from CD73-targeted therapy. Here, we evaluated the ability of In-labeled antibody 067-213, which has high affinity for human CD73, to act as a noninvasive imaging probe.},
 title = {Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression.},
 volume = {21},
 year = {2020}
}